✦ LIBER ✦

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

✍ Scribed by Torres, Vicente E.; Chapman, Arlene B.; Devuyst, Olivier; Gansevoort, Ron T.; Grantham, Jared J.; Higashihara, Eiji; Perrone, Ronald D.; Krasa, Holly B.; Ouyang, John; Czerwiec, Frank S.

Book ID: 119938844
Publisher: Massachusetts Medical Society
Year: 2012
Tongue: English
Weight: 897 KB
Volume: 367
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJMoa1205511

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on: Tolvaptan in Patients Wit

Commentary on: Tolvaptan in Patients With Autosomal-Dominant Polycystic Kidney Disease

✍ Black, Peter; Sutton, Roger 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Short-term effects of tolvaptan on renal

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

✍ Irazabal, Maria V; Torres, Vicente E; Hogan, Marie C; Glockner, James; King, Ber 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

Tolvaptan in Autosomal Dominant Polycyst

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease

📂 Article 📅 2013 🏛 Massachusetts Medical Society 🌐 English ⚖ 327 KB

Review of Tolvaptan for Autosomal Domina

Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

✍ Baur, Brian P.; Meaney, Calvin J. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Everolimus in Patients with Autosomal Do

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease

✍ Walz, Gerd; Budde, Klemens; Mannaa, Marwan; Nürnberger, Jens; Wanner, Christoph; 📂 Article 📅 2010 🏛 Massachusetts Medical Society 🌐 English ⚖ 717 KB

Autosomal dominant polycystic kidney dis

Autosomal dominant polycystic kidney disease

✍ Vicente E Torres; Peter C Harris; Yves Pirson 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 403 KB